This month, a new update has been released regarding ranitidine drugs. Pharmascience Inc. recalls certain lots of prescription and over-the-counter ranitidine as a precaution Pharmascience Inc. is recalling 13 lots of prescription and over-the-counter ranitidine drugs (150 mg tablets) after tests found NDMA, a nitrosamine impurity, at below but close to the accepted level. Please refer to the Affected Products table below for detailed information on the recalled lots.
Click here for more information.